Imfinzi Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Description

Imfinzi is a sterile, preservative-free, clear to opalescent, colourless to slightly yellow solution, free from visible particles.
Imfinzi is a human immunoglobulin (IgG1κ) monoclonal antibody.
Each mL of concentrate for solution for infusion contains 50 mg of durvalumab.
One vial of 2.4 mL of concentrate contains 120 mg of durvalumab.
One vial of 10 mL of concentrate contains 500 mg of durvalumab.
Excipients/Inactive Ingredients: Histidine, Histidine hydrochloride monohydrate, Trehalose dihydrate, Polysorbate 80, Water for injections.

Manufacturer:

AstraZeneca

Distributor:

DKSH